Environmental risk assessment of paroxetine

Environmental Science and Technology

Volumn 38, Issue 12, 2004, Pages 3351-3359

  Cunningham, Virginia L ^a   Constable, David J C ^a   Hannah, Robert E ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; BYPRODUCTS; DISEASE CONTROL; DRUG PRODUCTS; DRUG THERAPY; METABOLISM; PHOTOLYSIS; RISK ASSESSMENT; WASTEWATER TREATMENT;

PANIC DISORDERS; PAROXETINE (PA);

ENVIRONMENTAL ENGINEERING;

DRUG METABOLITE; PAROXETINE;

CHEMICAL POLLUTANT; ENVIRONMENTAL FATE; ENVIRONMENTAL RISK;

ACTIVATED SLUDGE; AQUATIC ENVIRONMENT; ARTICLE; BIODEGRADATION; CONCENTRATION (PARAMETERS); DRUG EXCRETION; DRUG METABOLISM; ENVIRONMENTAL IMPACT; ENVIRONMENTAL MONITORING; PHOTOLYSIS; PHYSICAL CHEMISTRY; RISK ASSESSMENT; WASTE WATER MANAGEMENT;

ANIMALS; BIODEGRADATION, ENVIRONMENTAL; DAPHNIA; LETHAL DOSE 50; PAROXETINE; PHOTOCHEMISTRY; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS; SEWAGE; VIBRIO; WASTE DISPOSAL, FLUID;

DAPHNIA; DAPHNIA MAGNA;

EID: 3042807074     PISSN: 0013936X     EISSN: None     Source Type: Journal    
DOI: 10.1021/es035119x     Document Type: Article

References (39)

1. Ternes, T. A. Occurrence of Drugs in German Sewage Treatment Plants and Rivers. Water Res. 1998, 32, 3245-3260.
2. Halling-Sorensen, B.; Nielsen, S. N.; Lanzky, P. F.; Ingerslev, F.; Lutzheft, H. C. H.; Jorgensen, S. E. Occurrence, Fate and Effects of Pharmaceutical Substances in the Environment - A Review. Chemosphere 1998, 36, 357-393.
3. Ternes, T. A.; Stumpf, M.; Mueller, J.; Haberer, K.; Wilken, R. D.; Servos, M. Behaviour and occurrence of estrogens in municipal sewage treatment plants - I. Investigations in Germany, Canada and Brazil. Sci. Total Environ. 1999, 225, 81-90.
4. Daughton, C. G.; Ternes, T. A. Pharmaceutical and Personal Care Products in the Environment: Agents of Subtle Change? Environ. Health Perspect. 1999, 107, 907-938.
5. McQuillan, D.; Parker, J.; Chapman, T. H.; Sherrell, K.; Mills, D. Drug residues in ambient water: initial surveillance in New Mexico, USA. NGWA, 2nd International Conference on Pharmaceuticals and Endocrine Disrupting Chemicals in Water, 2001.
6. Kuemmerer, K. Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks; Springer-Verlag: Berlin, Heidelberg, New York, 2001.
7. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data. Toxicol. Lett. 2002, 131, 5-17.
8. Kolpin, D. W.; Furlong, E. T.; Meyer, M. T.; Thurman, E. M.; Zaugg, S. D.; Barber, L. B.; Buxton, H. T. Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999-2000: A National Reconnaissance. Environ. Sci. Technol. 2002, 36, 1202-1211. [Including the following: Kolpin, D. W.; Furlong, E. T.; Meyer, M. T.; Thurman, E. M.; Zaugg, S. D.; Barber, L. B.; Buxton, H. T. Response to Comment on "Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999-2000: A National Reconnaissance". Environ. Sci. Technol. 2002, 36, 4007-4008. (Correspondence/Rebuttal)].
9. Kolpin, D. W.; Furlong, E. T.; Meyer, M. T.; Thurman, E. M.; Zaugg, S. D.; Barber, L. B.; Buxton, H. T. Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999-2000: A National Reconnaissance. Environ. Sci. Technol. 2002, 36, 1202-1211. [Including the following: Kolpin, D. W.; Furlong, E. T.; Meyer, M. T.; Thurman, E. M.; Zaugg, S. D.; Barber, L. B.; Buxton, H. T. Response to Comment on "Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999-2000: A National Reconnaissance". Environ. Sci. Technol. 2002, 36, 4007-4008. (Correspondence/Rebuttal)].
10. Paxil (paroxetine hydrochloride). Physician's Desk Reference; Medical Economics Company, Inc.: Montvale, NJ, 2002; p 1609.
11. Haddock, R. E.; Johnson, A. M.; Langley, P. F.; Nelson, D. R.; Pope, J. A.; Thomas, D. R.; Woods, F. R. Metabolic pathway of paroxetine in animals and man, and the comparative pharmacological properties of its metabolites. Acta Psychiatr. Scand., Suppl. 1989, 350, 24-26.
12. Mohle, E.; Metzger, J. W. Drugs in Municipal Sewage Effluents: Screening and Biodegradation Studies. In Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues; Daughton, C. G., Jone-Lepp, T., Eds.; ACS Symposium Series 791, 2001; Chapter 11, p 203.
13. Ternes, T. A.; Krechel, P.; Mueller, I. Behaviour and occurrence of estrogens in municipal sewage treatment plants - II. Aerobic batch experiments with activated sludge. Sci. Total Environ. 1999, 225, 91-99.
14. Kozak, R. G.; D'Haese, I.; Verstraete, W. Pharmaceuticals in the Environment: Focus on 17-ethinyloestradiol. In Pharmaceuticals in the Environment; Kuemmerer, K., Ed.; Springer-Verlag: Berlin, 2001; Chapter 6, p 50.
15. Anderson, P. D.; D'Aco, V. I.; Shanahan, P.; Chapra, S. C.; Buzby, M. E.; Cunningham, V. L.; DuPlessie, B. M.; Hayes, E. P.; Mastrocco, F.; Parke, N. J.; Rader, J. C.; Samuelian, J. H.; Schwab, B. W. Screening Analysis of Human Pharmaceutical Compounds in U.S. Surface Waters. Environ. Sci. Technol. 2004, 38, 838-849.
16. Eirkson, C.; Harrass, M. C.; Osbourne, C. M.; Sayre, P. G.; Zeeman, M. Water solubility. In Environmental Assessment Technical Assistance Handbook; PB87-175345; U.S. Food and Drug Administration: Washington, DC, 1987; Vol. 3.01, pp 1-11.
17. Albert, A.; Serjeant, E. P. The Determination of Ionization Constants; Chapman and Hall: New York, 1984.
18. UV-Vis Absorption Spectra. OECD Guidelines for Testing of Chemicals 101. OECD (Organisation for Economic Cooperation and Development), Paris, France, 1981.
19. Eirkson, C.; Harrass, M. C.; Osbourne, C. M.; Sayre, P. G.; Zeeman, M. N-Octanol/Water Partition Coefficient. In Environmental Assessment Technical Assistance Handbook; PB87-175345; U.S. Food and Drug Administration: Washington, DC, 1987; Vol. 3.02, pp 1-9.
20. Eirkson, C.; Harrass, M. C.; Osbourne, C. M.; Sayre, P. G.; Zeeman, M. Sorption and Desorption. In Environmental Assessment Technical Assistance Handbook; PB87-175345; U.S. Food and Drug Administration: Washington, DC, 1987; Vol. 3.09, pp 1-13.
21. Eirkson, C.; Harrass, M. C.; Osbourne, C. M.; Sayre, P. G.; Zeeman, M. Aerobic biodegradation in water. In Environmental Assessment Technical Assistance Handbook; PB87-175345; U.S. Food and Drug Administration: Washington, DC, 1987; Vol. 3.11, pp 1-18.
22. Standard Methods for the Examination of Water and Wastewater, 17th ed.; American Public Health Association: Washington, DC, 1989.
23. Eirkson, C.; Harrass, M. C.; Osbourne, C. M.; Sayre, P. G.; Zeeman, M. Hydrolysis. In Environmental Assessment Technical Assistance Handbook; PB87-175345; U.S. Food and Drug Administration: Washington, DC, 1987; Vol. 3.09, pp 1-6.
24. Eirkson, C.; Harrass, M. C.; Osbourne, C. M.; Sayre, P. G.; Zeeman, M. Photodegradation. In Environmental Assessment Technical Assistance Handbook; PB87-175345; U.S. Food and Drug Administration: Washington, DC, 1987; Vol. 3.10, pp 1-8.
25. Determination of Photolysis Rate and Rate Constant. Standard Test Method for Conducting Aqueous Direct Photolysis Tests. Annual Book of ASTM Standards; ASTM E896-87; American Society for Testing Materials: Philadelphia, PA, 1991; Vol. 11.05.
26. Standard Test Method for Biodegradation By a Shake-Flask Die-Away Method. Annual Book of ASTM Standards; ASTM E1279-89; American Society for Testing Materials: Philadelphia, PA, 1989; Vol. 11.05.
27. OECD Guidelines for Testing Chemicals; Organisation for Economic Cooperation and Development, 1981; Section 209.
28. Stephan, C. E. Methods for Calculating an LC50. In Aquatic Toxicology and Hazard Evaluation; ASTM Special Technical Publication 634; Mayer, F. L., Hamelink, J. L., Eds.; ASTM: Philadelphia, PA, 1977.
29. A Microtox Manual. How to Run Toxicity Tests Using the Microtox Model 500; Microbics Corporation: Carlsbad, CA.
30. Eirkson, C.; Harrass, M. C.; Osbourne, C. M.; Sayre, P. G.; Zeeman, M. Daphnia Acute Toxicity. In Environmental Assessment Technical Assistance Handbook; PB87-175345; U.S. Food and Drug Administration: Washington, DC, 1987; Vol. 4.08, pp 1-25.
31. Standard Guide for Conducting Acute Toxicity Test with Fishes, Macroinvertebrates, and Amphibians. ASTM E729-88a.
32. Hansch, C.; Leo, A. Exploring QSAR: Fundamentals and Applications in Chemistry and Biology; American Chemical Society: Washington, DC, 1995; Chapter 4.
33. Brooks, et al. Select Pharmaceutical Accumulation in Fish Liver, Brain and Muscle, Abstract; Geological Society of America, November, 2003.
34. Handbook of Chemical Property Estimation Methods; Lyman, W. J., Reehl, W. F., Rosenblatt, D. H., Eds.; American Chemical Society: Washington, DC, 1990; Chapters 1, 2, 4, 5.
35. Barton, D. A.; McKeown, J. J. Field Verification of Predictive Modeling of Organic Compound Removal by Biological Wastewater Treatment Processes. Environ. Prog. 1991, 10, pp 96-103.
36. Tolls, J. Sorption of Veterinary Pharmaceuticals in Soils: A Review. Environ. Sci. Technol. 2001, 35, pp 3397-3406.
37. Guidance for Industry Environmental Assessment of Human Drug and Biologics Applications; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), July 1999, CMC 6, Revision 1.
38. 1996 Needs Survey; EPA 832-F-99-058; 1999.
39. Cowan, C. C.; Larson, R. J.; Feijtel, T. C.; Rapaport, R. A. An Improved Model for Predicting the Fate of Consumer Product Chemicals in Wastewater Treatment Plants. Water Res. 1993, 27, pp 561-573.